Stay updated on Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision number was updated from v3.5.2 to v3.5.3, indicating a general platform/software revision rather than a change to the trial record details.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded last known status details and Poitiers University Hospital with date 2023-01 and verification; updated the revision to v3.5.2 and removed the previous v3.5.0.SummaryDifference0.9%

- Check53 days agoChange DetectedAdded revision v3.5.0 to the record history and removed v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision history shows an update from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedNew revision entry v3.4.2 is added and v3.4.1 is removed in the study's record history. This reflects internal version tracking rather than substantive changes to trial information.SummaryDifference0.1%

- Check96 days agoChange DetectedThe history shows a minor revision from v3.4.0 to v3.4.1, with no substantive changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.